SharesGrow 7-Criteria Score
All 7 criteria scored · valuation-related highlighted on this page
Sensorion S.A. (SENOF) .
Criteria proven by this page:
- VALUE (0/100, Fail) — the composite valuation score falls below the 60/100 threshold required to pass.
Overall SharesGrow Score: 35/100 with 0/7 criteria passed.
SharesGrow 7-Criteria Score
~
HEALTH
50/100
Debt-to-Equity & liquidity
→ Health
Valuation Snapshot — SENOF
Valuation Multiples
P/E (TTM)0.0
Forward P/EN/A
PEG RatioN/A
Forward PEGN/A
P/B Ratio0.00
P/S Ratio0.07
EV/EBITDA0.0
Per Share Data
EPS (TTM)$-1.49
Book Value / Share$0.00
Revenue / Share$39.42
FCF / Share$0.00
Yields & Fair Value
Earnings YieldN/A
Dividend Yield0.00%
Earnings Per Share (EPS) History
| Year |
EPS (Diluted) |
Revenue |
Net Income |
Net Margin |
| 2014 |
$2.45 |
$29.01B |
$2.14B |
7.4% |
| 2015 |
$3.48 |
$32.2B |
$2.93B |
9.1% |
| 2016 |
$-0.46 |
$33.73B |
$-372.4M |
-1.1% |
| 2017 |
$-1.20 |
$28.31B |
$-966.77M |
-3.4% |
| 2018 |
$-2.61 |
$30.19B |
$-2.11B |
-7% |
| 2019 |
$1.48 |
$33.45B |
$1.2B |
3.6% |
| 2020 |
$1.71 |
$39.47B |
$1.38B |
3.5% |
| 2021 |
$0.62 |
$48.34B |
$499.39M |
1% |
| 2022 |
$-2.96 |
$53.81B |
$-3.12B |
-5.8% |
| 2023 |
$-1.49 |
$53.62B |
$-2.03B |
-3.8% |
